For example, UBE3A degrades ZNF185 to activate the NOTCH pathway [17]; UBE3A targets SIRT6 in an ANXA2-dependent manner, leading to tumorigenesis of liver cancer [18]. This evidence concerns the gene UBE3A and liver cancer.